These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 816655)

  • 41. [The effects of estradiol and prolactin on DMBA-induced mammary tumor in rats].
    Kawasaki T; Sakamoto S; Okamoto R
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):797-804. PubMed ID: 3093613
    [No Abstract]   [Full Text] [Related]  

  • 42. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
    Daniel CP; Gaskell SJ; Nicholson RI
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin.
    Vignon F; Rochefort H
    Endocrinology; 1976 Mar; 98(3):722-9. PubMed ID: 177271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perphenazine and testosterone metabolism by mammary tumours in oophorectomized rats [proceedings].
    Buchan P; Miller WR
    Biochem Soc Trans; 1978; 6(1):135-6. PubMed ID: 416977
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhancement of DMBA induced mammary tumours by intermittent whole body hyperthermia (42 degrees C).
    Lahiri T; Deomina N; Dedov II; Lahiri P
    Endocrinol Jpn; 1981 Oct; 28(5):569-74. PubMed ID: 6807669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of oestrogen-stimulated prolactin release by anti-oestrogens.
    Jordan VC; Koerner S; Robison C
    J Endocrinol; 1975 Apr; 65(1):151-2. PubMed ID: 1141808
    [No Abstract]   [Full Text] [Related]  

  • 47. Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifen.
    Nicholson RI; Davies P; Griffiths K
    J Endocrinol; 1977 Apr; 73(1):135-42. PubMed ID: 404379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Arafah BM; Manni A; Pearson OH
    Endocrinology; 1980 Nov; 107(5):1364-9. PubMed ID: 6253265
    [No Abstract]   [Full Text] [Related]  

  • 49. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone and drug effects on growth of DMBA mammary tumours and plasma prolactin levels in adreno-ovariectomized rats.
    Minasian-Batmanian LC; Jabara AG
    Br J Cancer; 1981 Jun; 43(6):832-41. PubMed ID: 6788061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in morphology and hormone dependency following transplantation of rat 9,10-Dimethyl-1,2-benzanthracene-induced mammary adenocarcinoma.
    Horn H; Erlichman I; Geier A; Levij IS
    Eur J Cancer (1965); 1976 Mar; 12(3):189-94. PubMed ID: 820559
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of oophorectomy on progesterone metabolism in DMBA-induced mammary tumours of the rat.
    Mori M; Tominaga T; Kitamura M; Saito T; Tamaoki B
    Eur J Cancer (1965); 1980 Oct; 16(10):1373-5. PubMed ID: 6781909
    [No Abstract]   [Full Text] [Related]  

  • 53. Biodistribution and scintigraphy of 11C-toremifene in rats bearing DMBA-induced mammary carcinoma.
    Kangas L; Haaparanta M; Paul R; Roeda D; Sipilä H
    Pharmacol Toxicol; 1989 Apr; 64(4):373-7. PubMed ID: 2526330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of danazol on proliferation and viability of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in rats.
    Yoshimura S; Sakamoto S; Kudo H; Suzuki S; Sassa S; Matsubara M; Nagasawa H
    Anticancer Res; 1995; 15(1):61-5. PubMed ID: 7733642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM; Friesen HG
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of pituitary and mammary tumors in male, "fale" and female rats by either DMBA, estradiol implant or combined treatment.
    Kao KJ; Ramirez VD
    Proc Soc Exp Biol Med; 1979 Mar; 160(3):296-301. PubMed ID: 107519
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
    di Salle E; Zaccheo T; Ornati G
    J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
    Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
    J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ; Kledzik GS; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings: Effects of oestradiol-17 beta and ICI 46,474 on total and accessible cytoplasmic oestradiol-17 beta receptors in dimethylbenzanthracene-induced rat mammary tumours.
    Nicholson RI; Golder MP; Davies P; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):50P-51P. PubMed ID: 181519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.